83_FR_2467 83 FR 2456 - Agency Information Collection Activities; Proposed Collection; Comment Request; Veterinary Feed Directive

83 FR 2456 - Agency Information Collection Activities; Proposed Collection; Comment Request; Veterinary Feed Directive

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 83, Issue 11 (January 17, 2018)

Page Range2456-2459
FR Document2018-00676

The Food and Drug Administration (FDA, Agency or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of our veterinary feed directive (VFD) regulation.

Federal Register, Volume 83 Issue 11 (Wednesday, January 17, 2018)
[Federal Register Volume 83, Number 11 (Wednesday, January 17, 2018)]
[Notices]
[Pages 2456-2459]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00676]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0155]


Agency Information Collection Activities; Proposed Collection; 
Comment Request; Veterinary Feed Directive

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, Agency or we) is 
announcing an opportunity for public comment on the proposed collection 
of certain information by the Agency. Under the Paperwork Reduction Act 
of 1995 (PRA), Federal Agencies are required to publish notice in the 
Federal Register concerning each proposed collection of information, 
including each proposed extension of an existing collection of 
information, and to allow 60 days for public comment in response to the 
notice. This notice solicits comments on the information collection 
provisions of our veterinary feed directive (VFD) regulation.

DATES: Submit either electronic or written comments on the collection 
of information by March 19, 2018.

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. Electronic comments 
must be submitted on or before March 19, 2018. The https://www.regulations.gov electronic filing system will accept comments until 
midnight Eastern Time at the end of March 19, 2018. Comments received 
by mail/hand delivery/courier (for written/paper submissions) will be 
considered timely if they are postmarked or the delivery service 
acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to

[[Page 2457]]

the docket unchanged. Because your comment will be made public, you are 
solely responsible for ensuring that your comment does not include any 
confidential information that you or a third party may not wish to be 
posted, such as medical information, your or anyone else's Social 
Security number, or confidential business information, such as a 
manufacturing process. Please note that if you include your name, 
contact information, or other information that identifies you in the 
body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2010-N-0155 for ``Agency Information Collection Activities; 
Proposed Collection; Comment Request; Veterinary Feed Directive.'' 
Received comments, those filed in a timely manner (see ADDRESSES), will 
be placed in the docket and, except for those submitted as 
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff office between 9 
a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on https://www.regulations.gov. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly available, you 
can provide this information on the cover sheet and not in the body of 
your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: https://www.thefederalregister.org/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal 
Agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes Agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
requires Federal Agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, 
before submitting the collection to OMB for approval. To comply with 
this requirement, FDA is publishing notice of the proposed collection 
of information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) Whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques, when 
appropriate, and other forms of information technology.

Veterinary Feed Directive--21 CFR 558.6

OMB Control Number 0910-0363--Extension

    Section 504 of the Federal Food, Drug, and Cosmetic Act (the FD&C 
Act) (21 U.S.C. 354) establishes a regulatory category for certain new 
animal drugs called VFD drugs. Our VFD regulation is set forth at Sec.  
558.6 (21 CFR 558.6). VFD drugs are new animal drugs intended for use 
in or on animal feed which are limited to use under the professional 
supervision of a licensed veterinarian in the course of the 
veterinarian's professional practice (Sec.  558.3 (21 CFR 
558.3(b)(6))). An animal feed containing a VFD drug or a combination 
VFD drug may be fed to animals only by or upon a lawful VFD issued by a 
licensed veterinarian (Sec.  558.6(a)(1)).
    Veterinarians issue three copies of the VFD: one for their own 
records, one for their client, and one to the client's VFD feed 
distributor (Sec. Sec.  558.6(a)(4) and 558.6(b)(8)-(9)). The VFD 
includes information about the number and species of animals to receive 
feed containing one or more of the VFD drugs (Sec.  558.6(b)(3)), along 
with other information required under Sec.  558.6. All distributors of 
medicated feed containing VFD drugs must notify us of their intent to 
distribute such feed and must maintain records of the receipt and 
distribution of all medicated feeds containing VFD drugs.
    The VFD regulation ensures the protection of public health while 
enabling animal producers to obtain and use needed drugs as efficiently 
and cost-effectively as possible. The VFD regulation is tailored to the 
unique circumstances relating to the distribution and use of animal 
feeds containing a VFD drug.
    We will use the information collected to assess compliance with the 
VFD regulation. The required recordkeeping and third party disclosures 
provide assurance that the medicated feeds will be safe and effective 
for their labeled conditions of use and that edible

[[Page 2458]]

products from treated animals will be free of unsafe drug residues.
    We estimate the burden of this collection of information as 
follows. We base our estimates on our analysis of the information 
collection provisions of the final rule entitled ``Veterinary Feed 
Directive,'' published in the Federal Register of June 3, 2015 (80 FR 
31708 at 31728) (the June 3, 2015, final rule).

A. Reporting Requirements

    Description of Respondents: VFD Feed Distributors, VFD Drug 
Sponsors.
    A distributor of animal feed containing a VFD drug must notify us 
prior to the first time it distributes the VFD feed (Sec.  
558.6(c)(5)). This notification is required one time per distributor 
and must include the information set forth in Sec.  558.6(c)(5). In 
addition, a distributor must notify us within 30 days of any change in 
ownership, business name, or business address (Sec.  558.6(c)(6)). 
Additional reporting burdens for current VFD drug sponsors are approved 
under OMB control numbers 0910-0032 (New Animal Drug Applications) and 
0910-0669 (Abbreviated New Animal Drug Applications).
    FDA estimates the burden of this collection of information as 
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                   Number of
   21 CFR section, activity        Number of    responses  per   Total annual    Average burden     Total hours
                                  respondents      respondent      responses      per response
----------------------------------------------------------------------------------------------------------------
558.6(c)(5); requires a                    300               1             300  .125 (7 minutes)            37.5
 distributor to notify us
 prior to the first time it
 distributes a VFD feed.
558.6(c)(6); requires a                     20               1              20  .125 (7 minutes)             2.5
 distributor to notify us
 within 30 days of any change
 in ownership, business name,
 or business address.
                                                                                                 ---------------
    Total.....................  ..............  ..............  ..............  ................              40
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

B. Recordkeeping Requirements

    Description of Respondents: VFD Feed Distributors, Food Animal 
Veterinarians, and Clients (Food Animal Producers).
    As stated previously, veterinarians issue three copies of the VFD: 
One for their own records, one for their client, and one to the 
client's VFD feed distributor. All involved parties (the veterinarian, 
the distributor, and the client) must retain a copy of the VFD for 2 
years (Sec.  558.6(a)(4)). In addition, VFD feed distributors must also 
keep receipt and distribution records of VFD feeds they manufacture and 
make them available for inspection by us for 2 years (Sec.  
558.6(c)(3)).
    If a distributor manufactures the VFD feed, the distributor must 
also keep VFD manufacturing records for 1 year in accordance with 21 
CFR part 225 and such records must be made available for inspection and 
copying by FDA upon request (Sec.  558.6(c)(4)). These record 
requirements are currently approved under OMB control number 0910-0152, 
``Current Good Manufacturing Practice Regulations for Medicated Feed.'' 
Distributors may distribute VFD to another distributor only if the 
originating distributor first obtains a written acknowledgement letter. 
Such letters, like VFDs, are also subject to a 2-year record retention 
requirement (Sec.  558.6(c)(8)).

                               Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                   Number of                     Average burden
   21 CFR section, activity        Number of      records per    Total annual          per          Total hours
                                 recordkeepers   recordkeeper       records       recordkeeping
----------------------------------------------------------------------------------------------------------------
558.6(a)(4); required                   13,050           114.9       1,500,000  .0167 (1 minute)          25,050
 recordkeeping by
 veterinarians and producers.
558.6(a)(4), (c)(3)-(4), and             1,376           545.1         750,000  .0167 (1 minute)          12,525
 (c)(8); required
 recordkeeping by distributors.
                                                                                                 ---------------
    Total.....................  ..............  ..............  ..............  ................          37,575
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

C. Third-Party Disclosure Requirements

    Description of Respondents: VFD Drug Sponsors, Food Animal 
Veterinarians, VFD Feed Distributors, and Clients.
    Our regulation requires that veterinarians include the information 
specified at Sec.  558.6(b)(3) through (5) on the VFD. Additional 
requirements relating to the VFD are specified at Sec.  558.6(b)(7) 
through (9). A distributor may only distribute a VFD feed to another 
distributor for further distribution if the originating distributor 
(consignor) first obtains a written acknowledgement letter from the 
receiving distributor (consignee) before the feed is shipped (Sec.  
558.6(c)(8)).

[[Page 2459]]



                           Table 3--Estimated Annual Third-Party Disclosure Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                   Number of
                                   Number of      disclosures    Total annual    Average burden
   21 CFR section, activity       respondents         per         disclosures    per disclosure     Total hours
                                                  respondent
----------------------------------------------------------------------------------------------------------------
558.6(b)(3)-(5) and (b)(7)-              3,050             246         750,000  .125 (7 minutes)          93,750
 (9); required disclosures
 when a veterinarian issues a
 VFD.
558.6(c)(8); required                    1,000               5           5,000  .125 (7 minutes)             625
 disclosure (acknowledgement
 letter) from one distributor
 to another.
                                                                                                 ---------------
    Total.....................  ..............  ..............  ..............  ................          94,375
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    The VFD regulation also contains several labeling provisions that 
are exempt from OMB review and approval under the PRA because they are 
a ``public disclosure of information originally supplied by the Federal 
government to the recipient for the purpose of disclosure to the 
public'' (5 CFR 1320.3(c)(2)) and therefore do not constitute a 
``collection of information'' under the PRA (44 U.S.C. 3501, et seq.). 
All labeling and advertising for VFD drugs, combination VFD drugs, and 
feeds containing VFD drugs or combination VFD drugs must prominently 
and conspicuously display the following cautionary statement: 
``Caution: Federal law restricts medicated feed containing this 
veterinary feed directive (VFD) drug to use by or on the order of a 
licensed veterinarian'' (Sec.  558.6(a)(6)). In addition, the 
veterinarian must ensure that the following statement is included on 
the VFD (Sec.  558.6(b)(3)(xiii)): ``Use of feed containing this 
veterinary feed directive (VFD) drug in a manner other than as directed 
on the labeling (extralabel use) is not permitted.''
    The veterinarian may restrict VFD authorization to only include the 
VFD drug(s) cited on the VFD or such authorization may be expanded to 
allow the use of the cited VFD drug(s) along with one or more over-the-
counter animal drugs in an approved, conditionally approved, or indexed 
combination VFD drug (Sec.  558.6(b)(6)). The veterinarian must affirm 
his or her intent regarding combination VFD drugs by including one of 
the following statements on the VFD:
    1. ``This VFD only authorizes the use of the VFD drug(s) cited in 
this order and is not intended to authorize the use of such drug(s) in 
combination with any other animal drugs'' (Sec.  558.6(b)(6)(i)).
    2. ``This VFD authorizes the use of the VFD drug(s) cited in this 
order in the following FDA-approved, conditionally approved, or indexed 
combination(s) in medicated feed that contains the VFD drug(s) as a 
component.'' (List specific approved, conditionally approved, or 
indexed combination medicated feeds following this statement. Sec.  
558.6(b)(6)(ii).)
    3. ``This VFD authorizes the use of the VFD drug(s) cited in this 
order in any FDA-approved, conditionally approved, or indexed 
combination(s) in medicated feed that contains the VFD drug(s) as a 
component'' (Sec.  558.6(b)(6)(iii)).
    These labeling statements are not subject to review by OMB because, 
as stated previously, they are a ``public disclosure of information 
originally supplied by the Federal government to the recipient for the 
purpose of disclosure to the public'' (5 CFR 1320.3(c)(2)) and 
therefore do not constitute a ``collection of information'' under the 
PRA (44 U.S.C. 3501, et seq.). Our estimate of the annual burden for 
this information collection has not changed since the last OMB 
approval, which was associated with the June 3, 2015, final rule. 
However, the one-time burdens that we included in our analysis of the 
June 3, 2015, final rule (80 FR 31708 at 31729 to 31732) are not 
included in our current estimate.

    Dated: January 11, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-00676 Filed 1-16-18; 8:45 am]
 BILLING CODE 4164-01-P



                                               2456                       Federal Register / Vol. 83, No. 11 / Wednesday, January 17, 2018 / Notices

                                                                            TABLE 1—ANDAS FOR WHICH FDA IS WITHDRAWING APPROVAL—Continued
                                                   Application No.                                           Drug                                                                    Applicant

                                               ANDA 075375 ..........     Diltiazem Hydrochloride (HCl) Injection, 5 mg/milliliter (mL)                    Mylan Laboratories, Ltd., c/o Mylan Pharmaceuticals, Inc.,
                                                                                                                                                             781 Chestnut Ridge Rd., P.O. Box 4310, Morgantown,
                                                                                                                                                             WV 26504.
                                               ANDA 076911 ..........     Clorazepate Dipotassium Tablets USP, 3.75 mg, 7.5 mg,                            Sun Pharmaceutical Industries, Ltd., c/o Sun Pharma-
                                                                            and 15 mg.                                                                       ceutical Industries, Inc., 2 Independence Way, Princeton,
                                                                                                                                                             NJ 08540.
                                               ANDA 077102 ..........     Calcitriol Injection, 0.001 mg/mL ...........................................    Sagent Pharmaceuticals, Inc., 1901 N. Roselle Rd., Suite
                                                                                                                                                             450, Schaumburg, IL 60195.
                                               ANDA 084656 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Roxane Laboratories, Inc., 1809 Wilson Rd., Columbus,
                                                                            mg/30 mg.                                                                        OH 43228.
                                               ANDA 087977 ..........     Diphenhydramine HCl Capsules, 25 mg ..............................               LNK International, Inc., 145 Ricefield Ln., Hauppauge, NY
                                                                                                                                                             11788.
                                               ANDA 088676 ..........     Methylprednisolone Sodium Succinate for Injection USP,                           LyphoMed, Division of Fujisawa USA, Inc., 2045 North
                                                                            Equivalent to 40 mg base/vial.                                                   Cornell Ave., Melrose Park, IL 60160.
                                               ANDA 089080 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Purepac Pharmaceutical Co., 200 Elmora Ave., Elizabeth,
                                                                            mg/30 mg.                                                                        NJ 07207.
                                               ANDA 089183 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Superpharm Corp., 1769 Fifth Ave., Bayshore, NY 11706.
                                                                            mg/15 mg.
                                               ANDA 089253 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Do.
                                                                            mg/30 mg.
                                               ANDA 089219 ..........     Procainamide HCl Capsules USP, 250 mg, 375 mg, and                               IDT Australia, Ltd., c/o Facet Life Sciences, Inc., 6122
                                                                            500 mg.                                                                          Stone Wolfe Dr., Glen Carbon, IL 62034.
                                               ANDA 089254 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Do.
                                                                            mg/60 mg.
                                               ANDA 089369 ..........     Procainamide HCl Extended-Release Tablets USP, 250                               Do.
                                                                            mg, 500 mg, and 750 mg.
                                               ANDA 089481 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             American Therapeutics, Inc., 75 Carlough Rd., Bohemia,
                                                                            mg/15 mg.                                                                        NY 11716.
                                               ANDA 089482 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Do.
                                                                            mg/30 mg.
                                               ANDA 089483 ..........     Acetaminophen and Codeine Phosphate Tablets USP, 300                             Do.
                                                                            mg/60 mg.
                                               ANDA 206711 ..........     Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15                          Ajanta Pharma, Ltd., c/o Ajanta Pharma USA, Inc., One
                                                                            mg, and 20 mg.                                                                   Grande Commons, 440 U.S. Highway 22 East, Suite
                                                                                                                                                             150, Bridgewater, NJ 08807.



                                                  Therefore, approval of the                              DEPARTMENT OF HEALTH AND                                      collection provisions of our veterinary
                                               applications listed in table 1, and all                    HUMAN SERVICES                                                feed directive (VFD) regulation.
                                               amendments and supplements thereto,                                                                                      DATES: Submit either electronic or
                                               is hereby withdrawn as of February 16,                     Food and Drug Administration                                  written comments on the collection of
                                               2018. Introduction or delivery for                                                                                       information by March 19, 2018.
                                               introduction into interstate commerce of                   [Docket No. FDA–2010–N–0155]                                  ADDRESSES: You may submit comments
                                               products without approved new drug                                                                                       as follows. Please note that late,
                                               applications violates section 301(a) and                   Agency Information Collection
                                                                                                          Activities; Proposed Collection;                              untimely filed comments will not be
                                               (d) of the Federal Food, Drug, and                                                                                       considered. Electronic comments must
                                               Cosmetic Act (21 U.S.C. 331(a) and (d)).                   Comment Request; Veterinary Feed
                                                                                                          Directive                                                     be submitted on or before March 19,
                                               Drug products that are listed in table 1                                                                                 2018. The https://www.regulations.gov
                                               that are in inventory on the date that                     AGENCY:      Food and Drug Administration,                    electronic filing system will accept
                                               this notice becomes effective (see the                     HHS.                                                          comments until midnight Eastern Time
                                               DATES section) may continue to be                          ACTION:     Notice.                                           at the end of March 19, 2018. Comments
                                               dispensed until the inventories have                                                                                     received by mail/hand delivery/courier
                                               been depleted or the drug products have                    SUMMARY:   The Food and Drug                                  (for written/paper submissions) will be
                                               reached their expiration dates or                          Administration (FDA, Agency or we) is                         considered timely if they are
                                               otherwise become violative, whichever                      announcing an opportunity for public                          postmarked or the delivery service
                                               occurs first.                                              comment on the proposed collection of                         acceptance receipt is on or before that
                                                                                                          certain information by the Agency.                            date.
                                                 Dated: January 11, 2018.
                                                                                                          Under the Paperwork Reduction Act of
                                               Leslie Kux,                                                                                                              Electronic Submissions
                                                                                                          1995 (PRA), Federal Agencies are
                                               Associate Commissioner for Policy.                         required to publish notice in the                               Submit electronic comments in the
ethrower on DSK3G9T082PROD with NOTICES




                                               [FR Doc. 2018–00695 Filed 1–16–18; 8:45 am]                Federal Register concerning each                              following way:
                                               BILLING CODE 4164–01–P                                     proposed collection of information,                             • Federal eRulemaking Portal:
                                                                                                          including each proposed extension of an                       https://www.regulations.gov. Follow the
                                                                                                          existing collection of information, and                       instructions for submitting comments.
                                                                                                          to allow 60 days for public comment in                        Comments submitted electronically,
                                                                                                          response to the notice. This notice                           including attachments, to https://
                                                                                                          solicits comments on the information                          www.regulations.gov will be posted to


                                          VerDate Sep<11>2014   17:14 Jan 16, 2018   Jkt 244001    PO 00000     Frm 00035     Fmt 4703    Sfmt 4703       E:\FR\FM\17JAN1.SGM   17JAN1


                                                                          Federal Register / Vol. 83, No. 11 / Wednesday, January 17, 2018 / Notices                                             2457

                                               the docket unchanged. Because your                      redacted/blacked out, will be available                the information will have practical
                                               comment will be made public, you are                    for public viewing and posted on                       utility; (2) the accuracy of FDA’s
                                               solely responsible for ensuring that your               https://www.regulations.gov. Submit                    estimate of the burden of the proposed
                                               comment does not include any                            both copies to the Dockets Management                  collection of information, including the
                                               confidential information that you or a                  Staff. If you do not wish your name and                validity of the methodology and
                                               third party may not wish to be posted,                  contact information to be made publicly                assumptions used; (3) ways to enhance
                                               such as medical information, your or                    available, you can provide this                        the quality, utility, and clarity of the
                                               anyone else’s Social Security number, or                information on the cover sheet and not                 information to be collected; and (4)
                                               confidential business information, such                 in the body of your comments and you                   ways to minimize the burden of the
                                               as a manufacturing process. Please note                 must identify this information as                      collection of information on
                                               that if you include your name, contact                  ‘‘confidential.’’ Any information marked               respondents, including through the use
                                               information, or other information that                  as ‘‘confidential’’ will not be disclosed              of automated collection techniques,
                                               identifies you in the body of your                      except in accordance with 21 CFR 10.20                 when appropriate, and other forms of
                                               comments, that information will be                      and other applicable disclosure law. For               information technology.
                                               posted on https://www.regulations.gov.                  more information about FDA’s posting
                                                 • If you want to submit a comment                     of comments to public dockets, see 80                  Veterinary Feed Directive—21 CFR
                                               with confidential information that you                  FR 56469, September 18, 2015, or access                558.6
                                               do not wish to be made available to the                 the information at: https://www.gpo.gov/               OMB Control Number 0910–0363—
                                               public, submit the comment as a                         fdsys/pkg/FR-2015-09-18/pdf/2015-                      Extension
                                               written/paper submission and in the                     23389.pdf.
                                               manner detailed (see ‘‘Written/Paper                                                                              Section 504 of the Federal Food, Drug,
                                                                                                          Docket: For access to the docket to
                                               Submissions’’ and ‘‘Instructions’’).                                                                           and Cosmetic Act (the FD&C Act) (21
                                                                                                       read background documents or the
                                                                                                                                                              U.S.C. 354) establishes a regulatory
                                               Written/Paper Submissions                               electronic and written/paper comments
                                                                                                                                                              category for certain new animal drugs
                                                                                                       received, go to https://
                                                  Submit written/paper submissions as                                                                         called VFD drugs. Our VFD regulation is
                                                                                                       www.regulations.gov and insert the
                                               follows:                                                                                                       set forth at § 558.6 (21 CFR 558.6). VFD
                                                                                                       docket number, found in brackets in the
                                                  • Mail/Hand delivery/Courier (for                    heading of this document, into the
                                                                                                                                                              drugs are new animal drugs intended for
                                               written/paper submissions): Dockets                                                                            use in or on animal feed which are
                                                                                                       ‘‘Search’’ box and follow the prompts
                                               Management Staff (HFA–305), Food and                                                                           limited to use under the professional
                                                                                                       and/or go to the Dockets Management
                                               Drug Administration, 5630 Fishers                                                                              supervision of a licensed veterinarian in
                                                                                                       Staff, 5630 Fishers Lane, Rm. 1061,
                                               Lane, Rm. 1061, Rockville, MD 20852.                                                                           the course of the veterinarian’s
                                                                                                       Rockville, MD 20852.
                                                  • For written/paper comments                                                                                professional practice (§ 558.3 (21 CFR
                                                                                                       FOR FURTHER INFORMATION CONTACT: Ila
                                               submitted to the Dockets Management                                                                            558.3(b)(6))). An animal feed containing
                                               Staff, FDA will post your comment, as                   S. Mizrachi, Office of Operations, Food                a VFD drug or a combination VFD drug
                                               well as any attachments, except for                     and Drug Administration, Three White                   may be fed to animals only by or upon
                                               information submitted, marked and                       Flint North, 10A–12M, 11601                            a lawful VFD issued by a licensed
                                               identified, as confidential, if submitted               Landsdown St., North Bethesda, MD                      veterinarian (§ 558.6(a)(1)).
                                               as detailed in ‘‘Instructions.’’                        20852, 301–796–7726, PRAStaff@                            Veterinarians issue three copies of the
                                                  Instructions: All submissions received               fda.hhs.gov.                                           VFD: one for their own records, one for
                                               must include the Docket No. FDA–                        SUPPLEMENTARY INFORMATION: Under the                   their client, and one to the client’s VFD
                                               2010–N–0155 for ‘‘Agency Information                    PRA (44 U.S.C. 3501–3520), Federal                     feed distributor (§§ 558.6(a)(4) and
                                               Collection Activities; Proposed                         Agencies must obtain approval from the                 558.6(b)(8)–(9)). The VFD includes
                                               Collection; Comment Request;                            Office of Management and Budget                        information about the number and
                                               Veterinary Feed Directive.’’ Received                   (OMB) for each collection of                           species of animals to receive feed
                                               comments, those filed in a timely                       information they conduct or sponsor.                   containing one or more of the VFD
                                               manner (see ADDRESSES), will be placed                  ‘‘Collection of information’’ is defined               drugs (§ 558.6(b)(3)), along with other
                                               in the docket and, except for those                     in 44 U.S.C. 3502(3) and 5 CFR                         information required under § 558.6. All
                                               submitted as ‘‘Confidential                             1320.3(c) and includes Agency requests                 distributors of medicated feed
                                               Submissions,’’ publicly viewable at                     or requirements that members of the                    containing VFD drugs must notify us of
                                               https://www.regulations.gov or at the                   public submit reports, keep records, or                their intent to distribute such feed and
                                               Dockets Management Staff office                         provide information to a third party.                  must maintain records of the receipt and
                                               between 9 a.m. and 4 p.m., Monday                       Section 3506(c)(2)(A) of the PRA (44                   distribution of all medicated feeds
                                               through Friday.                                         U.S.C. 3506(c)(2)(A)) requires Federal                 containing VFD drugs.
                                                  • Confidential Submissions—To                        Agencies to provide a 60-day notice in                    The VFD regulation ensures the
                                               submit a comment with confidential                      the Federal Register concerning each                   protection of public health while
                                               information that you do not wish to be                  proposed collection of information,                    enabling animal producers to obtain and
                                               made publicly available, submit your                    including each proposed extension of an                use needed drugs as efficiently and cost-
                                               comments only as a written/paper                        existing collection of information,                    effectively as possible. The VFD
                                               submission. You should submit two                       before submitting the collection to OMB                regulation is tailored to the unique
                                               copies total. One copy will include the                 for approval. To comply with this                      circumstances relating to the
                                               information you claim to be confidential                requirement, FDA is publishing notice                  distribution and use of animal feeds
                                               with a heading or cover note that states                of the proposed collection of                          containing a VFD drug.
ethrower on DSK3G9T082PROD with NOTICES




                                               ‘‘THIS DOCUMENT CONTAINS                                information set forth in this document.                   We will use the information collected
                                               CONFIDENTIAL INFORMATION.’’ The                            With respect to the following                       to assess compliance with the VFD
                                               Agency will review this copy, including                 collection of information, FDA invites                 regulation. The required recordkeeping
                                               the claimed confidential information, in                comments on these topics: (1) Whether                  and third party disclosures provide
                                               its consideration of comments. The                      the proposed collection of information                 assurance that the medicated feeds will
                                               second copy, which will have the                        is necessary for the proper performance                be safe and effective for their labeled
                                               claimed confidential information                        of FDA’s functions, including whether                  conditions of use and that edible


                                          VerDate Sep<11>2014   17:14 Jan 16, 2018   Jkt 244001   PO 00000   Frm 00036   Fmt 4703   Sfmt 4703   E:\FR\FM\17JAN1.SGM   17JAN1


                                               2458                               Federal Register / Vol. 83, No. 11 / Wednesday, January 17, 2018 / Notices

                                               products from treated animals will be                                    A. Reporting Requirements                                                    within 30 days of any change in
                                               free of unsafe drug residues.                                              Description of Respondents: VFD                                            ownership, business name, or business
                                                  We estimate the burden of this                                        Feed Distributors, VFD Drug Sponsors.                                        address (§ 558.6(c)(6)). Additional
                                               collection of information as follows. We                                   A distributor of animal feed                                               reporting burdens for current VFD drug
                                               base our estimates on our analysis of the                                containing a VFD drug must notify us                                         sponsors are approved under OMB
                                                                                                                        prior to the first time it distributes the                                   control numbers 0910–0032 (New
                                               information collection provisions of the
                                                                                                                        VFD feed (§ 558.6(c)(5)). This                                               Animal Drug Applications) and 0910–
                                               final rule entitled ‘‘Veterinary Feed
                                                                                                                        notification is required one time per                                        0669 (Abbreviated New Animal Drug
                                               Directive,’’ published in the Federal                                                                                                                 Applications).
                                               Register of June 3, 2015 (80 FR 31708                                    distributor and must include the
                                               at 31728) (the June 3, 2015, final rule).                                information set forth in § 558.6(c)(5). In                                     FDA estimates the burden of this
                                                                                                                        addition, a distributor must notify us                                       collection of information as follows:

                                                                                                           TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
                                                                                                                                      Number of
                                                                                                           Number of                   responses                Total annual
                                                       21 CFR section, activity                                                                                                                Average burden per response                              Total hours
                                                                                                          respondents                     per                    responses
                                                                                                                                      respondent

                                               558.6(c)(5); requires a distributor to                                     300                             1                      300      .125 (7 minutes) ...............................                      37.5
                                                 notify us prior to the first time it
                                                 distributes a VFD feed.
                                               558.6(c)(6); requires a distributor to                                        20                           1                       20      .125 (7 minutes) ...............................                       2.5
                                                 notify us within 30 days of any
                                                 change in ownership, business
                                                 name, or business address.

                                                    Total ...........................................    ........................   ........................   ........................   ...........................................................             40
                                                  1 There   are no capital costs or operating and maintenance costs associated with this collection of information.


                                               B. Recordkeeping Requirements                                            2 years (§ 558.6(a)(4)). In addition, VFD                                    request (§ 558.6(c)(4)). These record
                                                  Description of Respondents: VFD                                       feed distributors must also keep receipt                                     requirements are currently approved
                                               Feed Distributors, Food Animal                                           and distribution records of VFD feeds                                        under OMB control number 0910–0152,
                                               Veterinarians, and Clients (Food Animal                                  they manufacture and make them                                               ‘‘Current Good Manufacturing Practice
                                               Producers).                                                              available for inspection by us for 2 years                                   Regulations for Medicated Feed.’’
                                                  As stated previously, veterinarians                                   (§ 558.6(c)(3)).                                                             Distributors may distribute VFD to
                                               issue three copies of the VFD: One for                                      If a distributor manufactures the VFD                                     another distributor only if the
                                               their own records, one for their client,                                 feed, the distributor must also keep VFD                                     originating distributor first obtains a
                                               and one to the client’s VFD feed                                         manufacturing records for 1 year in                                          written acknowledgement letter. Such
                                               distributor. All involved parties (the                                   accordance with 21 CFR part 225 and                                          letters, like VFDs, are also subject to a
                                               veterinarian, the distributor, and the                                   such records must be made available for                                      2-year record retention requirement
                                               client) must retain a copy of the VFD for                                inspection and copying by FDA upon                                           (§ 558.6(c)(8)).

                                                                                                        TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
                                                                                                                                       Number of
                                                                                                           Number of                                            Total annual
                                                       21 CFR section, activity                                                       records per                                          Average burden per recordkeeping                             Total hours
                                                                                                         recordkeepers                                            records
                                                                                                                                     recordkeeper

                                               558.6(a)(4); required recordkeeping                                   13,050                        114.9              1,500,000           .0167 (1 minute) ...............................                    25,050
                                                 by veterinarians and producers.
                                               558.6(a)(4), (c)(3)–(4), and (c)(8); re-                                 1,376                      545.1                 750,000          .0167 (1 minute) ...............................                    12,525
                                                 quired recordkeeping by distribu-
                                                 tors.

                                                    Total ...........................................    ........................   ........................   ........................   ...........................................................         37,575
                                                  1 There   are no capital costs or operating and maintenance costs associated with this collection of information.


                                               C. Third-Party Disclosure Requirements                                     Our regulation requires that                                               another distributor for further
                                                                                                                        veterinarians include the information                                        distribution if the originating distributor
                                                 Description of Respondents: VFD                                        specified at § 558.6(b)(3) through (5) on                                    (consignor) first obtains a written
                                               Drug Sponsors, Food Animal                                               the VFD. Additional requirements                                             acknowledgement letter from the
ethrower on DSK3G9T082PROD with NOTICES




                                               Veterinarians, VFD Feed Distributors,                                    relating to the VFD are specified at                                         receiving distributor (consignee) before
                                               and Clients.                                                             § 558.6(b)(7) through (9). A distributor                                     the feed is shipped (§ 558.6(c)(8)).
                                                                                                                        may only distribute a VFD feed to




                                          VerDate Sep<11>2014       17:14 Jan 16, 2018        Jkt 244001       PO 00000        Frm 00037        Fmt 4703       Sfmt 4703       E:\FR\FM\17JAN1.SGM              17JAN1


                                                                                  Federal Register / Vol. 83, No. 11 / Wednesday, January 17, 2018 / Notices                                                                                                 2459

                                                                                             TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1
                                                                                                                                     Number of
                                                                                                          Number of                  disclosures               Total annual
                                                       21 CFR section, activity                                                                                                              Average burden per disclosure                             Total hours
                                                                                                         respondents                     per                   disclosures
                                                                                                                                     respondent

                                               558.6(b)(3)–(5) and (b)(7)-(9); re-                                     3,050                         246                 750,000         .125 (7 minutes) ...............................                    93,750
                                                 quired disclosures when a veteri-
                                                 narian issues a VFD.
                                               558.6(c)(8); required disclosure (ac-                                   1,000                             5                  5,000        .125 (7 minutes) ...............................                       625
                                                 knowledgement letter) from one
                                                 distributor to another.

                                                    Total ...........................................   ........................   ........................   ........................   ...........................................................         94,375
                                                  1 There   are no capital costs or operating and maintenance costs associated with this collection of information.


                                                  The VFD regulation also contains                                     drug(s) as a component.’’ (List specific                                     SUMMARY:   The Food and Drug
                                               several labeling provisions that are                                    approved, conditionally approved, or                                         Administration (FDA or the Agency) has
                                               exempt from OMB review and approval                                     indexed combination medicated feeds                                          determined the regulatory review period
                                               under the PRA because they are a                                        following this statement.                                                    for AXUMIN and is publishing this
                                               ‘‘public disclosure of information                                      § 558.6(b)(6)(ii).)                                                          notice of that determination as required
                                               originally supplied by the Federal                                        3. ‘‘This VFD authorizes the use of the                                    by law. FDA has made the
                                               government to the recipient for the                                     VFD drug(s) cited in this order in any                                       determination because of the
                                               purpose of disclosure to the public’’ (5                                FDA-approved, conditionally approved,                                        submission of an application to the
                                               CFR 1320.3(c)(2)) and therefore do not                                  or indexed combination(s) in medicated                                       Director of the U.S. Patent and
                                               constitute a ‘‘collection of information’’                              feed that contains the VFD drug(s) as a                                      Trademark Office (USPTO), Department
                                               under the PRA (44 U.S.C. 3501, et seq.).                                component’’ (§ 558.6(b)(6)(iii)).                                            of Commerce, for the extension of a
                                               All labeling and advertising for VFD                                      These labeling statements are not                                          patent which claims that human drug
                                               drugs, combination VFD drugs, and                                       subject to review by OMB because, as                                         product.
                                               feeds containing VFD drugs or                                           stated previously, they are a ‘‘public
                                               combination VFD drugs must                                                                                                                           DATES:  Anyone with knowledge that any
                                                                                                                       disclosure of information originally                                         of the dates as published (in the
                                               prominently and conspicuously display                                   supplied by the Federal government to                                        SUPPLEMENTARY INFORMATION section) are
                                               the following cautionary statement:                                     the recipient for the purpose of
                                               ‘‘Caution: Federal law restricts                                                                                                                     incorrect may submit either electronic
                                                                                                                       disclosure to the public’’ (5 CFR                                            or written comments and ask for a
                                               medicated feed containing this                                          1320.3(c)(2)) and therefore do not
                                               veterinary feed directive (VFD) drug to                                                                                                              redetermination by March 19, 2018.
                                                                                                                       constitute a ‘‘collection of information’’                                   Furthermore, any interested person may
                                               use by or on the order of a licensed                                    under the PRA (44 U.S.C. 3501, et seq.).
                                               veterinarian’’ (§ 558.6(a)(6)). In addition,                                                                                                         petition FDA for a determination
                                                                                                                       Our estimate of the annual burden for                                        regarding whether the applicant for
                                               the veterinarian must ensure that the                                   this information collection has not
                                               following statement is included on the                                                                                                               extension acted with due diligence
                                                                                                                       changed since the last OMB approval,                                         during the regulatory review period by
                                               VFD (§ 558.6(b)(3)(xiii)): ‘‘Use of feed                                which was associated with the June 3,
                                               containing this veterinary feed directive                                                                                                            July 16, 2018. See ‘‘Petitions’’ in the
                                                                                                                       2015, final rule. However, the one-time                                      SUPPLEMENTARY INFORMATION section for
                                               (VFD) drug in a manner other than as                                    burdens that we included in our
                                               directed on the labeling (extralabel use)                                                                                                            more information.
                                                                                                                       analysis of the June 3, 2015, final rule
                                               is not permitted.’’                                                     (80 FR 31708 at 31729 to 31732) are not                                      ADDRESSES: You may submit comments
                                                  The veterinarian may restrict VFD                                    included in our current estimate.                                            as follows. Please note that late,
                                               authorization to only include the VFD                                                                                                                untimely filed comments will not be
                                                                                                                         Dated: January 11, 2018.                                                   considered. Electronic comments must
                                               drug(s) cited on the VFD or such
                                               authorization may be expanded to allow                                  Leslie Kux,                                                                  be submitted on or before March 19,
                                               the use of the cited VFD drug(s) along                                  Associate Commissioner for Policy.                                           2018. The https://www.regulations.gov
                                               with one or more over-the-counter                                       [FR Doc. 2018–00676 Filed 1–16–18; 8:45 am]                                  electronic filing system will accept
                                               animal drugs in an approved,                                            BILLING CODE 4164–01–P                                                       comments until midnight Eastern Time
                                               conditionally approved, or indexed                                                                                                                   at the end of March 19, 2018. Comments
                                               combination VFD drug (§ 558.6(b)(6)).                                                                                                                received by mail/hand delivery/courier
                                               The veterinarian must affirm his or her                                 DEPARTMENT OF HEALTH AND                                                     (for written/paper submissions) will be
                                               intent regarding combination VFD drugs                                  HUMAN SERVICES                                                               considered timely if they are
                                               by including one of the following                                                                                                                    postmarked or the delivery service
                                               statements on the VFD:                                                  Food and Drug Administration                                                 acceptance receipt is on or before that
                                                  1. ‘‘This VFD only authorizes the use                                                                                                             date.
                                               of the VFD drug(s) cited in this order                                  [Docket No. FDA–2016–E–3619]
                                                                                                                                                                                                    Electronic Submissions
                                               and is not intended to authorize the use
ethrower on DSK3G9T082PROD with NOTICES




                                               of such drug(s) in combination with any                                 Determination of Regulatory Review                                             Submit electronic comments in the
                                               other animal drugs’’ (§ 558.6(b)(6)(i)).                                Period for Purposes of Patent                                                following way:
                                                  2. ‘‘This VFD authorizes the use of the                              Extension; AXUMIN                                                              • Federal eRulemaking Portal:
                                               VFD drug(s) cited in this order in the                                  AGENCY:        Food and Drug Administration,                                 https://www.regulations.gov. Follow the
                                               following FDA-approved, conditionally                                   HHS.                                                                         instructions for submitting comments.
                                               approved, or indexed combination(s) in                                                                                                               Comments submitted electronically,
                                                                                                                       ACTION:       Notice.
                                               medicated feed that contains the VFD                                                                                                                 including attachments, to https://


                                          VerDate Sep<11>2014       17:14 Jan 16, 2018        Jkt 244001      PO 00000        Frm 00038        Fmt 4703       Sfmt 4703       E:\FR\FM\17JAN1.SGM              17JAN1



Document Created: 2018-10-26 09:57:18
Document Modified: 2018-10-26 09:57:18
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesSubmit either electronic or written comments on the collection of information by March 19, 2018.
ContactIla S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, [email protected]
FR Citation83 FR 2456 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR